These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 11139609)

  • 1. The transcriptional program of a human B cell line in response to Myc.
    Schuhmacher M; Kohlhuber F; Hölzel M; Kaiser C; Burtscher H; Jarsch M; Bornkamm GW; Laux G; Polack A; Weidle UH; Eick D
    Nucleic Acids Res; 2001 Jan; 29(2):397-406. PubMed ID: 11139609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
    Jochner N; Eick D; Zimber-Strobl U; Pawlita M; Bornkamm GW; Kempkes B
    EMBO J; 1996 Jan; 15(2):375-82. PubMed ID: 8617212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.
    Li Z; Van Calcar S; Qu C; Cavenee WK; Zhang MQ; Ren B
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8164-9. PubMed ID: 12808131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocations involving c-myc and c-myc function.
    Boxer LM; Dang CV
    Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DKC1 is a direct and conserved transcriptional target of c-MYC.
    Alawi F; Lee MN
    Biochem Biophys Res Commun; 2007 Nov; 362(4):893-8. PubMed ID: 17822678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes.
    Menssen A; Hermeking H
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6274-9. PubMed ID: 11983916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line.
    Schlosser I; Hölzel M; Hoffmann R; Burtscher H; Kohlhuber F; Schuhmacher M; Chapman R; Weidle UH; Eick D
    Oncogene; 2005 Jan; 24(3):520-4. PubMed ID: 15516975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of c-myc expression after heat shock in human B-cell lines is independent of 5' mRNA sequences.
    Wennborg A; Classon M; Klein G; von Gabain A
    Biol Chem Hoppe Seyler; 1995 Nov; 376(11):671-80. PubMed ID: 8962676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
    Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.
    Wang Y; Szekely L; Okan I; Klein G; Wiman KG
    Oncogene; 1993 Dec; 8(12):3427-31. PubMed ID: 8247547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-MYC impairs immunogenicity of human B cells.
    Schlee M; Schuhmacher M; Hölzel M; Laux G; Bornkamm GW
    Adv Cancer Res; 2007; 97():167-88. PubMed ID: 17419945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP downregulates c-myc expression by inhibition of transcript initiation in human B-precursor Reh cells.
    Andersson KB; Taskén K; Blomhoff HK
    FEBS Lett; 1994 Jan; 337(1):71-6. PubMed ID: 8276117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-7 induces N-myc and c-myc expression in normal precursor B lymphocytes.
    Morrow MA; Lee G; Gillis S; Yancopoulos GD; Alt FW
    Genes Dev; 1992 Jan; 6(1):61-70. PubMed ID: 1730410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decitabine represses translocated MYC oncogene in Burkitt lymphoma.
    Guan H; Xie L; Klapproth K; Weitzer CD; Wirth T; Ushmorov A
    J Pathol; 2013 Apr; 229(5):775-83. PubMed ID: 23341364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Myc inhibition negatively impacts lymphoma growth.
    Gomez-Curet I; Perkins RS; Bennett R; Feidler KL; Dunn SP; Krueger LJ
    J Pediatr Surg; 2006 Jan; 41(1):207-11; discussion 207-11. PubMed ID: 16410134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-myc Suppression in Burkitt's lymphoma cells.
    Simonsson T; Henriksson M
    Biochem Biophys Res Commun; 2002 Jan; 290(1):11-5. PubMed ID: 11779125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
    Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
    Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibition.
    Varano G; Raffel S; Sormani M; Zanardi F; Lonardi S; Zasada C; Perucho L; Petrocelli V; Haake A; Lee AK; Bugatti M; Paul U; Van Anken E; Pasqualucci L; Rabadan R; Siebert R; Kempa S; Ponzoni M; Facchetti F; Rajewsky K; Casola S
    Nature; 2017 Jun; 546(7657):302-306. PubMed ID: 28562582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.